You are looking for

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe. […]

In recent years, there has been increasing attention on how we can address the biggest challenges in healthcare: variation in patient outcomes, unsustainable cost increases, and low-value care. As populations age and the rates of chronic diseases rise, we have no choice but to rethink how we get value from healthcare spending.  In January, MedTech […]

Artificial intelligence (AI) has enormous potential to improve patient outcomes and reduce their variability, making health systems more efficient. But we must take an ethical approach to ensure sustainable implementation and public trust.   As leaders in the medical technology sector, we are playing our part in ensuring that our industry develops advanced data-driven technologies […]

Data-driven healthcare systems can deliver the personalised care that patients and payers are demanding more than ever. But who can deliver the data to support those systems? There are many players, but medical technology companies have a vital role to play. Medtech innovation has brought us real-world data collection, advanced data analytics, and machine learning […]

Even in 2019, cardiovascular diseases (CVD) remain the number 1 killer globally, accounting for almost 2 million deaths in the EU alone every year. These diseases are linked to huge inequalities, with more cardiovascular-related deaths in women than men, and more CVD-related deaths in middle-income than high-income countries, as a recent study from the European […]

Medical technology companies have a lot to consider when developing new products: a successful device must address an unmet need, deliver value to users and the health system, meet regulatory standards, and so on. But many companies are neglecting a key issue which is becoming increasingly essential – digital technologies and connected devices must be […]

Our recently published report examining the available treatment options for Atrial Fibrillation (AF) across Europe has found that millions of patients suffering with the condition don’t have access to a potentially life-saving treatment — catheter ablation therapy. Currently, 11 million people in Europe are affected by AF, a condition characterized by an irregular and often […]

In healthcare, the traditional role of procurement was to secure the availability of goods and services needed to deliver care. Once this was achieved, procurement moved one step up the ‘pyramid of procurement activities’: negotiating on product prices and discounts, in order to reduce spending on medical devices and consumables.  In recent years, things have […]